CClinicalTrials.gg
Not yet recruitingNCT05815563Updated Aug 30, 2023

Validation of Peripheral Perfusion Index in Predicting Successful Supraclavicular Brachial Plexus Block in Pediatrics

An observational study in Pediatrics and Anesthesia, Local, sponsored by Cairo University. Not yet recruiting at 1 site in Egypt. Open to participants aged 3 Years to 14 Years. Per ClinicalTrials.gov, last updated 2023-08-30.

Sponsored by Cairo University · Observational

From the registry’s dates

  • Primary completion was expected by Apr 2024, 2 years 6 months ago, but the record still lists the study as not yet recruiting.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
59
Ages
3 Years to 14 Years
Sex
All
01

Study summary

Few data are available for the PI as a tool for evaluation of peripheral block success in pediatric patients. Furthermore, there is currently no cut-off value defined for the accuracy of the PI in the detection of successful block.

Read the detailed description

modify plan for intraoperative and postoperative analgesia. Perfusion index is an assessment of the pulsatile strength at a monitoring site; it is calculated by means of pulse oximetry by expressing the pulsatile signal as a percentage of the non pulsatile signal by a specialized probe, both of which are derived from the amount of infrared light absorbed.PI can provide useful information about the peripheral perfusion status of the patients and works as an index for sympathetic stimulation. Recent study suggested that PI could be used as an early and sensitive indicator to assess the development of sympathectomy induced by brachial plexus block in conscious adults; it is more sensitive than other parameters such as changes of skin temperature gradients or mean arterial pressure (MAP)

02

Conditions studied

  • Pediatrics
  • Anesthesia, Local
03

In context

Lead sponsor

Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.

Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Years to 14 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

59 pediatric patients scheduled for elective upper extremity procedures will receive general anesthesia and trained anesthesiologist will perform ultrasound guided supraclavicular brachial plexus block on the ipsilateral side of the procedure.

Inclusion criteria

Age group: (3-14) years old. ASA class I-II

Exclusion criteria

Exclusion Criteria:

  • Patients with age below 3 year or older than 14 years. Parent refusal. Patients with apparent infection at site of needle insertion. Patients with any coagulation disorder. Patients with known neuropathy or brachial plexus injury. Patients with any cardiac, hepatic, renal or neurological disease
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
59 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Perfusion index

    The sensitivity of perfusion index in predicting success of supraclavicular brachial plexus block in pediatric patients.

    Time frame: Intraoperative

Secondary outcomes

  1. Temperature

    The sensitivity of temperature change in predicting success of supraclavicular brachial plexus block in pediatric patients.

    Time frame: Intraoperative

07

Study locations

1 site
  • Faculty of Medicine
    Cairo, 11562, Egypt
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 30, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05815563
Lead sponsor
Cairo University
Responsible party
mohamed abdelghany ali (Lecturer of anesthesia, Cairo University) — Principal investigator
First posted
Apr 18, 2023
Start date
Sep 2023 (estimated)
Primary completion
Apr 2024 (estimated)
Completion
May 2024 (estimated)
Last update
Aug 30, 2023

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion